Mohit Mathur

Company: Visterra

Job title: Director, Clinical Development

Seminars:

Exploring the Potentials of Complement Inhibition as a Therapeutic Strategy to Improve Kidney Transplant Outcomes 1:30 pm

Role of complement dysregulation in kidney transplant recipients Potential role for complement inhibition in improving kidney transplant outcomesRead more

day: Day 2 Track 2 PM

Panel Discussion | Novel Targets in Development for IgA Nephropathy: Where are the Current Late Phase Trials Heading? 11:00 am

From complement to APRIL to ETA: what targets are currently in development and looking most promising? Exploring new treatment possibilities with combinational targeting Exploring the current thinking on IgA pathogenesis to direct priorities for future target developmentRead more

day: Pre-Conference Seminar Day